There have been a few studies of SSTR2 expression and compared their clinicopathologic correlation, including patients’ survival in the pancreatic NETs, but no previous large cohort studies in rectal NETs. The gene discussed is SSTR2; the disease is rectum neuroendocrine neoplasm.